Improvements in vector design plus the use of latest biomaterials as nucleic acid carriers are now being pursued to boost security although increasing gene transfer effectiveness.Sort III hypersensitivity reactions arise when IgG and IgM antibodies bind to soluble proteins (as opposed to mobile surface molecules as in type II hypersensitivity react